CCND2 and cancer: In this particular cohort with a limited number of early stage cancers, we did not detect mutations in the following genes: ARID1A, KIT, PDGFRA, BRCA2, FGFR2, ALK, CCND1, PTEN, GNAS, FGFR3, CCND2, and RAF1.